See the DrugPatentWatch profile for jardiance
What conditions is Jardiance (empagliflozin) used to treat?
Jardiance (empagliflozin) is used to treat type 2 diabetes. It helps lower blood sugar by increasing glucose loss through the urine.[1]
In addition to diabetes, Jardiance is used in some patients to reduce the risk of cardiovascular death in adults with heart failure. It may also be used to lower the risk of hospitalization for heart failure in certain groups.[1]
Is Jardiance only for diabetes?
No. Although it is prescribed for type 2 diabetes, Jardiance is also used for specific heart-related indications (particularly heart failure) in adults, depending on the patient’s condition and eligibility.[1]
What does Jardiance do in the body?
Jardiance lowers blood glucose by blocking SGLT2 (sodium-glucose cotransporter 2) in the kidneys. This makes the kidneys excrete more glucose into the urine, which reduces blood sugar levels.[1]
Who should ask their doctor about whether Jardiance is appropriate?
Patients with type 2 diabetes who need additional blood sugar control may be candidates. Patients with heart failure may also ask whether Jardiance fits their treatment plan based on the heart failure type and overall health status.[1]
What do people commonly want to know before starting?
People often ask about whether Jardiance is safe with their other diabetes or heart medicines, how quickly it lowers sugars, and what side effects to watch for (especially urine infections or genital infections), because Jardiance increases glucose in urine.[1]
Sources:
1. https://www.drugs.com/jardiance.html